ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AC003102.1 | | | | | | | Tissue enriched |
AC132216.1 | HCG1785179; PRO1787; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enriched |
AC132872.2 | CDNA FLJ27256 fis, clone SYN09689; Uncharacterized protein | | | | | | Tissue enriched |
AHSP | Alpha hemoglobin stabilizing protein | Plasma proteins
| | | | | Tissue enriched |
AL590560.1 | HCG1995379; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enriched |
ALAS2 | Aminolevulinate, delta-, synthase 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
ANKLE1 | Ankyrin repeat and LEM domain containing 1 | Predicted membrane proteins
| | | | | Tissue enriched |
AZU1 | Azurocidin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C12orf79 | Chromosome 12 open reading frame 79 | | | | | | Tissue enriched |
C15ORF31 | | Predicted secreted proteins
| | | | | Tissue enriched |
C17orf99 | Chromosome 17 open reading frame 99 | Predicted secreted proteins
| | | | | Tissue enriched |
CAMP | Cathelicidin antimicrobial peptide | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CCM2L | Cerebral cavernous malformation 2-like | Plasma proteins
| | | | | Tissue enriched |
CCNL1 | Cyclin L1 | Predicted secreted proteins
| | | | | Tissue enriched |
CD5L | CD5 molecule-like | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CDT1 | Chromatin licensing and DNA replication factor 1 | Disease related genes
| | | | | Tissue enriched |
CEACAM8 | Carcinoembryonic antigen-related cell adhesion molecule 8 | CD markers Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CLEC11A | C-type lectin domain family 11, member A | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CST7 | Cystatin F (leukocystatin) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTB-186H2.3 | Uncharacterized protein | | | | | | Tissue enriched |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA3 | Defensin, alpha 3, neutrophil-specific | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
DEFA4 | Defensin, alpha 4, corticostatin | Predicted secreted proteins
| | | | | Tissue enriched |
DNTT | DNA nucleotidylexotransferase | Enzymes Plasma proteins
| | | | | Tissue enriched |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes
| | | | | Tissue enriched |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPB42 | Erythrocyte membrane protein band 4.2 | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
EPX | Eosinophil peroxidase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
EREG | Epiregulin | Predicted membrane proteins
| | | | | Tissue enriched |
FAM9C | Family with sequence similarity 9, member C | Predicted membrane proteins
| | | | | Tissue enriched |
FCAR | Fc fragment of IgA, receptor for | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
GATA1 | GATA binding protein 1 (globin transcription factor 1) | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enriched |
GFI1B | Growth factor independent 1B transcription repressor | Disease related genes Transcription factors
| | | | | Tissue enriched |
GPR97 | G protein-coupled receptor 97 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GYPA | Glycophorin A (MNS blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GYPB | Glycophorin B (MNS blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
H1FX | H1 histone family, member X | Plasma proteins
| | | | | Tissue enriched |
HBA1 | Hemoglobin, alpha 1 | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HBA2 | Hemoglobin, alpha 2 | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HBB | Hemoglobin, beta | Disease related genes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
HBCBP | HBcAg-binding protein; Uncharacterized protein | | | | | | Tissue enriched |
HBD | Hemoglobin, delta | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
HBM | Hemoglobin, mu | | | | | | Tissue enriched |
HBQ1 | Hemoglobin, theta 1 | | | | | | Tissue enriched |